# Critical Evaluation of Hypotheses
---
## Hypothesis 1: Calcineurin-FUNDC1 Axis
### Weak Links
1. **Mechanistic contradiction is unresolved.** The cited FUNDC1 paper (PMID: 23933753) demonstrates that calcineurin-mediated FUNDC1 dephosphorylation *promotes* mitophagy—this is the direct opposite of the MOMP induction claimed. The "paradox" in the neurodegenerative context is asserted, not mechanistically explained. FUNDC1 dephosphorylation does not intrinsically specify "mitophagy vs. apoptosis"; the model requires an additional unspecified checkpoint.
2. **Beclin-1 cleavage attribution is likely incorrect.** Calcineurin is a serine/threonine phosphatase; it does not directly cleave proteins. Beclin-1 cleavage during apoptosis is typically mediated by **caspase-3** (PMID: 28701345 appears to support caspase involvement, not calcineurin). Citing this paper as supporting calcineurin-mediated Beclin-1 cleavage is a category error that conflates the apoptotic pathway upstream of both events.
3. **Lysosomal dysfunction is disconnected from FUNDC1 signaling.** The model states lysosomal dysfunction blocks autophagosome-lysosome fusion, but offers no mechanistic bridge explaining how lysosomal failure redirects FUNDC1-mediated signaling toward MOMP instead of mitophagy. This makes the "paradox" grammatically complete but causally empty.
4. **PINK1/Park2 KO confounds the interpretation.** PINK1⁻/⁻ and Park2⁻/⁻ neurons have globally impaired mitophagy *independent* of FUNDC1. If FUNDC1 also directs mitophagy (partially via a PINK1-independent pathway), these genotypes create a double-deficiency background that may mask any effect of calcineurin manipulation.
### Counter-Evidence
- FUNDC1-dephosphorylated neurons overwhelmingly show mitophagy induction, not apoptosis (PMID: 23933753).
- Calcineurin inhibition (FK506) is neuroprotective in many AD/PD models—attributing this *only* to apoptosis suppression oversimplifies a multi-target drug effect.
- FUNDC1-independent MOMP pathways (Bax/Bak activation via Bcl-2 family) are the canonical drivers of mitochondrial apoptosis and are not described here.
### Falsifying Experiment
> Co-treat PINK1⁻/⁻ neurons with mitochondrial stress + calcineurin inhibitor and measure **cytochrome c release into cytosol** (intact mitochondria vs. apoptotic fractionation). If FUNDC1 dephosphorylation directs MOMP, FK506 should reduce cytosolic cytochrome c. A more direct test: overexpress FUNDC1 S13A vs. S13D in wild-type neurons under lysosomal inhibition (bafilomycin A1) and assay MOMP markers (cytochrome c, Smac/DIABLO release). If both phospho-states fail to induce MOMP, the central claim is falsified.
### Revised Confidence
**0.45** — The core premise that calcineurin can switch cell fate via FUNDC1 is mechanistically plausible but incompletely specified. The cited evidence for FUNDC1 and for Beclin-1 cleavage cuts against the hypothesis as stated, and the lysosomal dysfunction component lacks any mechanistic integration.
---
## Hypothesis 2: TREM2-Driven Phagocytic Receptor Cascades
### Weak Links
1. **TREM2 ligand specificity is imprecise.** TREM2 recognizes phosphatidylserine (PS) on **apoptotic bodies** broadly—this is its established DAMPH pathway function. The claim that TREM2 specifically senses mitochondrial PS exposure ("mito-DAMPs") lacks direct evidence. Mitochondrial fragments from damaged neurons expose PS because the entire cell is apoptotic; this does not constitute mitochondrial-specific recognition.
2. **p62/S409 phosphorylation is disconnected from phagocytosis.** p62 functions in **intracellular** aggrephagy and selective autophagy, recruited to ubiquitinated protein aggregates and damaged organelles. There is no established mechanism by which phosphorylated p62 enhances *extracellular* debris clearance by phagocytes. Extracellular particle uptake uses Fcγ receptors, complement receptors, and PS receptors—not p62.
3. **TREM2 is predominantly a microglial receptor; neuronal compartment is unaddressed.** The feedback loop requires astrocyte/neuronal p62/S409 phosphorylation downstream of TREM2, but neurons express minimal TREM2 (PMID: 28878125). The cross-talk model posits intercellular signaling from microglial TREM2 to neuronal p62 without specifying the ligand or receptor that transmits this signal across cells.
4. **The GSK3β citation is incomplete** (PMID truncated), raising concern about whether the cited source actually supports GSK3β-mediated p62/S409 phosphorylation in this context rather than a different phosphorylation site or cell type.
### Counter-Evidence
- TREM2 deficiency primarily impairs **clustering and proliferation** of microglia around amyloid plaques rather than specific debris clearance (PMID: 28878125).
- p62 knockout mice are viable with primary defects in ubiquitinated protein aggregate clearance—not mitochondrial debris phagocytosis.
- Neuroinflammation from TREM2 loss may be secondary to failed microglial metabolic adaptation, not failed mitochondrial debris clearance.
### F